Adjuvant Radiotherapy in Prostate Cancer Patients Treated with Surgery: The Impact of Age and Tumor Characteristics

Firas Abdollah, Pierre I. Karakiewicz, Giorgio Gandaglia, Deepansh Dalela, Dane E. Klett, Jonas Shiffmann, Francesco Montorsi, Alberto Briganti, Fred Saad, Markus Graefen, James O. Peabody, Mani Menon, Maxine Sun

Research output: Contribution to journalArticlepeer-review

Abstract

Background: The overall mortality (OM) and cancer-specific mortality (CSM) benefits of adjuvant radiotherapy (aRT) in treating prostate cancer (PCa) patients with adverse pathologic characteristics at radical prostatectomy (RP) are unclear. Objective: To test the impact of aRT on survival in PCa patients treated with RP according to adverse pathologic characteristics (Gleason score [GS] 8-10; pT3b/4, lymph node invasion [LNI]) and age categories (

Original languageEnglish
Pages (from-to)191-199
Number of pages9
JournalEuropean Urology Focus
Volume1
Issue number2
DOIs
Publication statusPublished - Sep 1 2015

Keywords

  • Adjuvant radiotherapy
  • Cancer-specific survival
  • Competing risks
  • Prostate cancer
  • Radical prostatectomy
  • Risk score

ASJC Scopus subject areas

  • Urology

Fingerprint Dive into the research topics of 'Adjuvant Radiotherapy in Prostate Cancer Patients Treated with Surgery: The Impact of Age and Tumor Characteristics'. Together they form a unique fingerprint.

Cite this